Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.64 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.63 |
| ▸ | NAMPT | P43490 | 1/20 | 0.62 |
| ▸ | PDE4A | P27815 | 1/20 | 0.61 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.61 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | RAB9A | P51151 | 2/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30873016 | 1.00 | MEN1 (0.70) | MEN1KMT2AALDH1A1CYP3A4TSHR | |
| SCHEMBL6926258 | 0.92 | ABCC1 (0.76) | MEN1KMT2AALDH1A1CYP3A4TSHR | |
| SCHEMBL10904567 | 0.88 | AURKB (0.72) | MEN1KMT2AALDH1A1CYP3A4TSHR | |
| SCHEMBL4141962 | 0.88 | MEN1 (0.89) | MEN1KMT2AALDH1A1CYP3A4TSHR | |
| SCHEMBL3245372 | 0.88 | NAMPT (0.65) | MEN1KMT2AALDH1A1PDE4DABCC1 | |
| Hydrochloric Acid SCHEMBL9638131 | 0.86 | MEN1 (0.86) | MEN1KMT2AALDH1A1CYP3A4TSHR | |
| SCHEMBL13997418 | 0.85 | MEN1 (0.70) | MEN1KMT2AALDH1A1CYP3A4TSHR | |
| SCHEMBL5724139 | 0.85 | NAMPT (0.66) | MEN1KMT2AALDH1A1ABCC1NAMPT | |
| SCHEMBL2218172 | 0.84 | ATM (0.64) | MEN1KMT2AALDH1A1CYP3A4PDE4D | |
| SCHEMBL6509106 | 0.84 | MEN1 (0.68) | MEN1KMT2AALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| US-10599060-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2020-03-24 | — | — | US | disclosed |
| US-10423090-B2 | Magenta toner and toner kit | CANON KABUSHIKI KAISHA (JP) | 2019-09-24 | — | — | US | disclosed |
| US-20190171125-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2019-06-06 | — | — | US | disclosed |
| US-20190171123-A1 | MAGENTA TONER AND TONER KIT | CANON KABUSHIKI KAISHA (JP) | 2019-06-06 | — | — | US | disclosed |
| US-20180307153-A1 | MAGENTA TONER | CANON KK (JP) | 2018-10-25 | — | — | US | disclosed |
| US-10036970-B2 | Magenta toner | CANON KABUSHIKI KAISHA (JP) | 2018-07-31 | — | — | US | disclosed |
| US-20170357168-A1 | MAGENTA TONER | CANON KABUSHIKI KAISHA (JP) | 2017-12-14 | — | — | US | disclosed |
| US-6528528-B2 | Inhibitors of 15-lipoxygenase, inhibiting chemotaxis of monocytes | WARNER-LAMBERT COMPANY | 2003-03-04 | — | — | US | disclosed |
| US-20010031874-A1 | Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis | CONNOR DAVID THOMAS (US) | 2001-10-18 | — | — | US | disclosed |
| US-6268387-B1 | INHIBITORS OF THE ENZYME 15-LIPOXYGENASE AND ARE INHIBITORS OF MONOCYTE CHEMOTAXIS. | WARNER-LAMBERT COMPANY | 2001-07-31 | — | — | US | disclosed |
| EP-1042276-A1 | THIOUREA COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY LLC (US) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999032433-A1 | THIOUREA AND BENZAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031874-A1 | Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis | TPMT, CTH, CBS | MEN1 3193/4885KMT2A 1976/4885ALDH1A1 369/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | MEN1 3411/4885KMT2A 1142/4885ALDH1A1 4390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.